Production (Stage)
Microbot Medical Inc.
MBOT
$2.62
-$0.02-0.76%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 23.32% | -5.51% | -30.43% | -3.96% | 24.83% |
Total Depreciation and Amortization | -42.31% | 13.04% | 64.29% | -50.00% | -20.00% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -9.54% | 0.71% | -15.11% | -26.93% | -81.55% |
Change in Net Operating Assets | -139.08% | 815.79% | -6.75% | 130.75% | 54.19% |
Cash from Operations | -69.96% | 38.71% | -40.98% | 19.13% | -32.89% |
Capital Expenditure | -85.71% | -- | 100.00% | 71.43% | -380.00% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -1,752.26% | 972.86% | -88.24% | 193.70% | -142.99% |
Cash from Investing | -1,760.87% | 967.86% | -88.20% | 192.37% | -143.42% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 881.85% | 347.39% | -69.48% | -13.48% | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 881.85% | 347.39% | -69.48% | -13.48% | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -96.13% | 232.73% | -252.42% | 199.69% | -215.05% |